Health and Ageing Portfolio


Health and Ageing Portfolio

Index to questions on notice (PDF 240KB)
(Updated 16 May 2013)

Answers to Questions on Notice

Responses to questions taken on notice at the Additional Budget Estimates hearings are due on Friday 5 April 2013 - standing order 74(5) takes effect 30 days after this date.

QoN

Department / Agency

Senator

Topic

Answer to QoN

Date answer received
1 Whole of Portfolio Fierravanti-Wells Budget Reporting Elements (PDF 4607KB) 14/05/2013
2 1 Xenophon Alcohol Advertising (PDF 273KB) 11/04/2013
3 1 Xenophon Alcohol Vouchers (PDF 230KB) 11/04/2013
4 2 Xenophon Home Medicines Review Program (PDF 426KB) 22/03/2013
5 2 Xenophon Home Medicines Review Program (PDF 389KB) 16/04/2013
6 2 Xenophon Home Medicines Review Program (PDF 213KB) 16/04/2013
7 2 Xenophon Home Medicines Review Program (PDF 173KB) 22/03/2013
8 1 Fierravanti-Wells Research grants (PDF 1977KB) 10/04/2013
9 1 Fierravanti-Wells Visit by Dr Karen Lee (PDF 291KB) 10/04/2013
10 1 Fierravanti-Wells Research Grants Approval (PDF 274KB) 10/04/2013
11 1 Fierravanti-Wells Responsibilities of DoHA and ANPHA (PDF 266KB) 10/04/2013
12 1 Fierravanti-Wells Cost of Swap It, Don't Stop It Campaign (PDF 355KB) 14/05/2013
13 12 Fierravanti-Wells Health Workforce Fund (PDF 488KB) 10/04/2013
14 12 Fierravanti-Wells Health Workforce Fund (PDF 229KB) 27/03/2013
15 12 Fierravanti-Wells 100 Places Program (PDF 158KB) 10/04/2013
16 1 Fierravanti-Wells Food Provided on Cruise Ships (PDF 268KB) 01/05/2013
17 1 Fierravanti-Wells Carbon Monoxide in Fish (PDF 404KB) 01/05/2013
18 1 Rhiannon International Bans on Testing Cosmetics on Animals (PDF 616KB) 03/05/2013
19 1 Rhiannon International Bans on Testing Cosmetics on Animals (PDF 262KB) 03/05/2013
20 1 Rhiannon International Bans on Testing Cosmetics on Animals (PDF 228KB) 03/05/2013
21 1 Rhiannon International Bans on Testing Cosmetics on Animals (PDF 512KB) 03/05/2013
22 4 Smith ACFI Monitoring Group (PDF 6677KB) 06/05/2013
23 4 Smith ACFI Monitoring Group Part 1 (PDF 15770KB)
Part 2 (PDF 19212KB)
Part 3 (PDF 17285KB)		 03/05/2013
24 4 Smith ACFI Monitoring Group (PDF 204KB) 08/04/2013
25 4 Smith Aged Care - Rural, Regional and Other Special Needs Building Fund (PDF 159KB) 08/04/2013
26 4 Smith Aged Care - Rural, Regional and Other Special Needs Building Fund (PDF 388KB) 11/04/2013
27 14 Di Natale National Surveillance Strategy (PDF 253KB) 04/04/2013
28 4 Smith Aged Care - Rural, Regional and Other Special Needs Building Fund (PDF 1051KB) 11/04/2013
29 14 Di Natale Antimicrobial Resistance (PDF 320KB) 04/04/2013
30 4 Smith Minister for Ageing (PDF 222KB) 11/04/2013
31 4 Smith Minister for Ageing (PDF 183KB) 08/04/2013
32 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 268KB) 14/05/2013
33 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 325KB) 26/04/2013
34 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 351KB) 09/04/2013
35 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 224KB) 09/04/2013
36 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 186KB) 09/04/2013
37 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 169KB) 14/05/2013
38 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 304KB) 14/05/2013
39 13 Bushby Public Hospitals and Information: Tasmanian Package (PDF 434KB) 14/05/2013
40 Whole of Portfolio Mason Absence Rate  (PDF 357KB) 19/03/2013
41 Whole of Portfolio Mason Leave (PDF 245KB) 19/03/2013
42 Whole of Portfolio Mason Unscheduled Absences (PDF 161KB) 19/03/2013
43 1 Boyce Foetal Alcohol Spectrum Disorder (PDF 558KB) 11/04/2013
44 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 344KB) 22/03/2013
45 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 244KB) 10/04/2013
46 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 151KB) 09/04/2013
47 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 161KB) 10/04/2013
48 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 153KB) 22/03/2013
49 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 239KB) 22/03/2013
50 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 512KB) 14/05/2013
51 2 Boyce Myozyme, a life saving drug used to treat Pompe Disease (PDF 205KB) 22/03/2013
52 2 Boyce Chemotherapy Drugs (PDF 204KB) 22/03/2013
53 2 Boyce Chemotherapy Drugs (PDF 278KB) 22/03/2013
54 2 Boyce Chemotherapy Drugs (PDF 239KB) 14/05/2013
55 2 Boyce Chemotherapy Drugs (PDF 266KB) 22/03/2013
56 2 Boyce Chemotherapy Drugs (PDF 178KB) 10/04/2013
57 2 Boyce Chemotherapy Drugs (PDF 178KB) 10/04/2013
58 2 Boyce Chemotherapy Drugs (PDF 173KB) 22/03/2013
59 2 Boyce Chemotherapy Drugs (PDF 345KB) 14/05/2013
60 5 Boyce QLD Super Clinics (PDF 225KB) 10/04/2013
61 5 Boyce QLD Super Clinics (PDF 231KB) 26/04/2013
62 5 Boyce QLD Super Clinics (PDF 229KB) 24/04/2013
63 5 Boyce QLD Super Clinics (PDF 171KB) 10/04/2013
64 5 Boyce QLD Super Clinics (PDF 208KB) 24/04/2013
65 5 Boyce QLD Super Clinics (PDF 177KB) 10/04/2013
66 5 Boyce QLD Super Clinics (PDF 150KB) 24/04/2013
67 5 Boyce QLD Super Clinics (PDF 193KB)  
68 5 Bushby After-hours medical care in Tasmania/Tasmania Medicare Local (TML) (PDF 290KB) 26/04/2013
69 Whole of Portfolio Boyce Staffing (PDF 212KB) 10/04/2013
70 Whole of Portfolio Boyce Staffing (PDF 247KB) 09/04/2013
71 Whole of Portfolio Boyce Staffing (PDF 154KB) 09/04/2013
72 Whole of Portfolio Boyce Making the Public Service more efficient (PDF 765KB) 14/05/2013
73 Whole of Portfolio Boyce Printing Costs (PDF 189KB) 27/03/2013
74 Whole of Portfolio Boyce Graduate Recruitment (PDF 186KB) 27/03/2013
75 Whole of Portfolio Boyce Graduate Training (PDF 135KB) 27/03/2013
76 Whole of Portfolio Boyce Advertising (PDF 1043KB) 09/04/2013
77 Whole of Portfolio Boyce Hospitality and Entertainment (PDF 1077KB) 14/05/2013
78 Whole of Portfolio Boyce Meeting Costs (PDF 239KB) 27/03/2013
79 Whole of Portfolio Boyce Program Launch Costs (PDF 351KB) 10/04/2013
80 Whole of Portfolio Boyce Board Appointments (PDF 1348KB) 27/03/2013
81 Whole of Portfolio Boyce Freedom of Information (PDF 470KB) 14/05/2013
82 Whole of Portfolio Boyce Community Cabinet Meetings (PDF 453KB) 24/04/2013
83 Whole of Portfolio Boyce Reviews (PDF 688KB) 14/05/2013
84 Whole of Portfolio Boyce Consultancies (PDF 296KB) 09/04/2013
85 Whole of Portfolio Boyce Media Monitoring (PDF 285KB) 27/03/2013
86 Whole of Portfolio Boyce Media Monitoring (PDF 272KB) 09/05/2013
87 Whole of Portfolio Boyce Social Media (PDF 220KB) 10/04/2013
88 Whole of Portfolio Boyce Social Media (PDF 283KB) 27/03/2013
89 Whole of Portfolio Boyce Social Media (PDF 188KB) 27/03/2013
90 Whole of Portfolio Boyce Internet (PDF 194KB) 09/04/2013
91 Whole of Portfolio Boyce Staff Amenities (PDF 185KB) 09/04/2013
92 Whole of Portfolio Boyce Staff Amenities (PDF 243KB) 27/03/2013
93 Whole of Portfolio Boyce Coffee Machines (PDF 220KB) 09/04/2013
94 Whole of Portfolio Boyce Contractors (PDF 546KB) 10/04/2013
95 Whole of Portfolio Boyce Media Subscriptions (PDF 1272KB) 14/05/2013
96 Whole of Portfolio Boyce Travel Costs (PDF 729KB) 14/05/2013
97 Whole of Portfolio Boyce Travel Costs (PDF 220KB) 09/04/2013
98 Whole of Portfolio Boyce Travel Costs (PDF 214KB) 14/05/2013
99 Whole of Portfolio Boyce Travel Costs (PDF 129KB) 09/04/2013
100 Whole of Portfolio Boyce Travel Costs (PDF 114KB) 09/04/2013
101 Whole of Portfolio Boyce Legal Costs (PDF 416KB) 14/05/2013
102 Whole of Portfolio Boyce Legal Costs (PDF 425KB) 14/05/2013
103 Whole of Portfolio Boyce Legal Costs (PDF 469KB) 14/05/2013
104 Whole of Portfolio Boyce Education Expenses (PDF 540KB) 09/04/2013
105 Whole of Portfolio Boyce Executive Coaching and Leadership Training (PDF 593KB) 09/04/2013
106 Whole of Portfolio Boyce Media Training (PDF 1148KB) 14/05/2013
107 Whole of Portfolio Boyce Paid Parental Leave (PDF 1631KB) 10/04/2013
108 Whole of Portfolio Boyce Training for Portfolio Minister and Parliamentary Secretaries (PDF 217KB) 09/04/2013
109 Whole of Portfolio Boyce Corporate Cars (PDF 217KB) 09/04/2013
110 Whole of Portfolio Boyce Taxi Costs (PDF 546KB) 14/05/2013
111 Whole of Portfolio Boyce Hire Cars (PDF 493KB) 14/05/2013
112 Whole of Portfolio Boyce Credit Cards (PDF 454KB) 27/03/2013
113 Whole of Portfolio Boyce Provision of Equipment (PDF 816KB) 09/04/2013
114 Whole of Portfolio Boyce Electricity Purchasing (PDF 182KB) 11/04/2013
115 Whole of Portfolio Boyce Briefings for the Australian Greens and Independents (PDF 346KB) 14/05/2013
116 Whole of Portfolio Boyce Shredders (PDF 268KB) 09/04/2013
117 Whole of Portfolio Boyce Protective Security Policy Framework (PDF 211KB) 09/04/2013
118 Whole of Portfolio Boyce Office Locations (PDF 1351KB) 09/04/2013
119 Whole of Portfolio Boyce Communications Staff (PDF 1539KB) 10/04/2013
120 Whole of Portfolio Boyce Grants (PDF 310KB) 24/04/2013
121 Whole of Portfolio Boyce Commissioned Reports (PDF 1352KB) 14/05/2013
122 Whole of Portfolio Boyce Government Payment of Accounts (PDF 407KB) 09/04/2013
123 Whole of Portfolio Boyce Stationery Requirements (PDF 235KB) 27/03/2013
124 2 Fierravanti-Wells Price Reductions (PDF 248KB) 14/05/2013
125 2 Di Natale Price Reductions (PDF 500KB) 14/05/2013
126 1 Fierravanti-Wells Tobacco Plain Packaging - Monthly Tracking Survey (PDF 376KB) 01/05/2013
127 1 Fierravanti-Wells Tobacco - Palatability Contract (PDF 166KB) 14/03/2013
128 1 Fierravanti-Wells Tobacco - National Class Action Lawsuit (PDF 244KB) 03/05/2013
129 11 Wright Mental Health Nurse Incentive Program (PDF 209KB) 11/04/2013
130 11 Wright Mental Health Nurse Incentive Program (PDF 184KB) 11/04/2013
131 11 Wright Mental Health Nurse Incentive Program (PDF 158KB) 08/04/2013
132 11 Wright Mental Health Nurse Incentive Program (PDF 193KB) 06/05/2013
133 11 Wright Mental Health Nurse Incentive Program (PDF 187KB) 08/04/2013
134 11 Wright Mental Health Nurse Incentive Program (PDF 192KB) 06/05/2013
135 11 Wright Mental Health Nurse Incentive Program (PDF 193KB) 08/04/2013
136 11 Wright Mental Health Nurse Incentive Program (PDF 203KB) 08/04/2013
137 11 Wright Mental Health working Group (PDF 406KB) 11/04/2013
138 11 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
139 11 Siewert * Transferred to cross portfolio Indigenous matters webpage    
140 1 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
141 13 Di Natale National Partnership Agreement on Hospital and Workforce Reform (PDF 285KB) 14/05/2013
142 1 Di Natale Food Regulation  (PDF 268KB) 17/04/2013
143 13 Di Natale Alcohol Health Warnings (PDF 235KB) 17/04/2013
144 1 Di Natale Voluntary Labelling Scheme (PDF 214KB) 17/04/2013
145 1 Di Natale Alcohol Industry Voluntary Labelling Regime (PDF 146KB) 17/04/2013
146 1 Di Natale Warning Labels for Alcohol (PDF 308KB) 17/04/2013
147 1 Di Natale Alcohol Warning Labels (PDF 174KB) 17/04/2013
148 1 Di Natale Fetal Alcohol Spectrum Disorders (PDF 208KB) 11/04/2013
149 1 Di Natale Fetal Alcohol Spectrum Disorders (PDF 219KB) 06/05/2013
150 1 Di Natale Fetal Alcohol Spectrum Disorders (PDF 193KB) 11/04/2013
151 1 Di Natale National Fetal Alcohol Spectrum Disorders Diagnostic Instrument (PDF 221KB) 11/04/2013
152 1 Di Natale Harmful Use of Alcohol (PDF 319KB) 11/04/2013
153 1 Di Natale National Alcohol Strategy (PDF 255KB) 11/04/2013
154 1 Di Natale National Health Priority Areas (PDF 2191KB) 14/05/2013
155 2 Di Natale PBAC Review (PDF 1408KB) 14/05/2013
156 14 Di Natale National Hepatitis C Strategy (PDF 991KB) 26/04/2013
157 2 Di Natale Lyrica (PDF 496KB) 26/04/2013
158 1 Di Natale Antimicrobial Resistance (PDF 369KB) 01/05/2013
159 1 Di Natale Antimicrobial Resistance (PDF 260KB) 30/04/2013
160 1 Di Natale Antibiotic Resistance (PDF 203KB) 30/04/2013
161 4 Di Natale Home and Community Care Program (PDF 635KB) 11/04/2013
162 1 Di Natale National Industrial Chemicals Notification and Assessment Scheme (PDF 146KB) 26/04/2013
163 1 Di Natale National Industrial Chemicals Notification and Assessment Scheme (PDF 275KB) 03/05/2013
164 1 Di Natale Titanium Dioxide in Sunscreen (PDF 1547KB) 01/05/2013
165 10 Boyce E-Health (PDF 239KB) 14/05/2013
166 10 Boyce PCEHR (PDF 464KB) 14/05/2013
167 10 Boyce PCEHR Audit Trail (PDF 161KB) 26/04/2013
168 10 Boyce PCEHR - Outages (PDF 204KB) 14/05/2013
169 1 Scullion Petrol Sniffing (PDF 153KB) 11/04/2013
170 1 Scullion * Transferred to cross portfolio Indigenous matters webpage    
171 1 Scullion Banned Drinkers Register/ Closing the Gap
Transferred to FaHCSIA		    
172 1 Madigan Gardasil (PDF 466KB) 04/04/2013
173 12 Madigan Accidents and Injuries (PDF 184KB) 19/03/2013
174 1 Madigan RU486 (PDF 293KB) 01/05/2013
175 1 Madigan RU486 (PDF 237KB) 04/04/2013
176 1 Fierravanti-Wells Data Plans - ACSQHC (PDF 496KB) 10/04/2013
177 1 Fierravanti-Wells Dietary Guidelines (PDF 259KB) 04/04/2013
178 1 Fierravanti-Wells Dietary Guidelines (PDF 248KB) 04/04/2013
179 1 Fierravanti-Wells Dietary Guidelines (PDF 157KB) 04/04/2013
180 4 Fierravanti-Wells Extra Service Status (PDF 644KB) 08/04/2013
181 5 Fierravanti-Wells Medicare Locals (PDF 145KB) 10/04/2013
182 12 Fierravanti-Wells Data Plans - HWA (PDF 441KB) 09/04/2013
183 1 Fierravanti-Wells Data Plans - IHPA (PDF 455KB) 14/05/2013
184 1 Fierravanti-Wells Training - IHPA (PDF 212KB) 10/04/2013
185 1 Fierravanti-Wells Training - IHPA (PDF 312KB) 09/04/2013
186 1 Fierravanti-Wells Cost Data - IHPA (PDF 372KB) 09/04/2013
187 1 Fierravanti-Wells Cost Data - IHPA (PDF 212KB) 09/04/2013
188 1 Fierravanti-Wells Data Plans - NHPA (PDF 417KB) 22/03/2013
189 1 Fierravanti-Wells Parkinsons (PDF 376KB) 17/04/2013
 190 13 Fierravanti-Wells Organ Donation (PDF 470KB) 30/04/2013
191 13 Fierravanti-Wells Organ Donation (PDF 965KB) 01/05/2013
192 4 Fierravanti-Wells Aged Care (PDF 1154KB) 08/04/2013
193 8 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
194 8 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
195 13 Di Natale Australian Organ and Tissue Donation and Transplant Authority  (PDF 1196KB) 14/05/2013
196 13 Di Natale Australian Organ and Tissue Donation and Transplant Authority (PDF 10260KB) 14/05/2013
197 13 Di Natale Australian Organ and Tissue Donation and Transplant Authority (PDF 10099KB) 14/05/2013
198 13 Di Natale Australian Organ and Tissue Donation and Transplant Authority (PDF 1343KB) 14/05/2013
199 13 Di Natale Australian Organ and Tissue Donation and Transplant Authority (PDF 191KB) 14/05/2013
200 13 Di Natale Australian Organ and Tissue Donation and Transplant Authority (PDF 200KB) 14/05/2013
201 13 Di Natale Organ Donors (PDF 271KB) 14/05/2013
202 1 Di Natale Mental Health Funding (PDF 244KB) 06/05/2013
203 1 Di Natale Mental Health Funding (PDF 390KB) 06/05/2013
204 1 Di Natale Mental Health Funding (PDF 183KB) 06/05/2013
205 1 Di Natale Mental Health Funding (PDF 358KB) 06/05/2013
206 2 Di Natale Home Medicines Review (PDF 397KB) 14/05/2013
207 2 Di Natale Home Medicines Review (PDF 308KB) 14/05/2013
208 2 Di Natale Home Medicines Review (PDF 148KB) 17/04/2013
209 2 Di Natale Home Medicines Review (PDF 267KB) 26/04/2013
210 2 Di Natale Home Medicines Review (PDF 261KB) 22/03/2013
211 2 Di Natale Home Medicines Review (PDF 215KB) 22/03/2013
212 2 Di Natale Home Medicines Review (PDF 239KB) 14/05/2013
213 2 Di Natale MedChecks (PDF 288KB) 14/05/2013
214 1 Xenophon Urogynaecological Mesh (PDF 866KB) 22/03/2013
215 1 Xenophon Medicine and Device Alerts/Communication (PDF 349KB) 01/05/2013
216 9 Fierravanti-Wells Private Health Insurance (PDF 141KB) 19/03/2013
217 10 Fierravanti-Wells Health and Hospital Fund (PDF 137KB) 09/04/2013
218 10 Fierravanti-Wells Health and Hospital Fund (PDF 127KB) 09/04/2013
219 10 Fierravanti-Wells Health and Hospital Fund (PDF 130KB) 09/04/2013
220 10 Fierravanti-Wells Health and Hospital Fund (PDF 3003KB) 14/05/2013
221 13 Fierravanti-Wells Public Hospitals and Information - Improving Public Hospital Services NPA - Mental Health  (PDF 508KB) 09/05/2013
222 13 Fierravanti-Wells Public Hospitals & Information - New Data Requirements (PDF 222KB) 03/05/2013
223 1 Edwards National Binge Drinking Strategy Sponsorship Program (PDF 1003KB) 11/04/2013
224 8 Siewert * Transferred to cross portfolio Indigenous matters webpage    
225 10 Fierravanti-Wells Health System Capacity and Quality (PDF 514KB) 14/05/2013
226 4 Fierravanti-Wells ACFI Fraud Investigations (PDF 212KB) 03/04/2013
227 13 Brown Organ Donation and Transplantation Data (PDF 776KB) 14/05/2013
228 5 Fierravanti-Wells Medicare Locals Funding (PDF 135KB) 10/04/2013
229 5 Fierravanti-Wells Medicare Locals  (PDF 161KB) 10/04/2013
230 5 Fierravanti-Wells Medicare Locals  (PDF 840KB) 26/04/2013
231 5 Fierravanti-Wells Medicare Locals Funding (PDF 130KB) 24/04/2013
232 4 Fierravanti-Wells Staff Involved in ACAT Assessments (PDF 270KB) 08/04/2013
233 4 Fierravanti-Wells Non-operational Bed Licences (PDF 205KB) 06/05/2013
234 4 Fierravanti-Wells Occupancy Rates in Aged Care (PDF 708KB) 06/05/2013
235 4 Furner ACAR Places in QLD (PDF 283KB) 08/04/2013
236 4 Smith Viability Supplement (PDF 279KB) 08/04/2013
237 4 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
238 4 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
239 9 Fierravanti-Wells Private Health Insurance  (PDF 203KB) 19/03/2013
240 1 Fierravanti-Wells Indian Clinical Trials - Total Overseas Cost (PDF 191KB) 04/04/2013
241 1 Fierravanti-Wells Indian Clinical Trials (PDF 142KB) 04/04/2013
242 1 Fierravanti-Wells Spelling of Fetus - Why (PDF 300KB) 04/04/2013
243 1 Fierravanti-Wells Spelling of Fetus - Cost (PDF 133KB) 14/05/2013
244 1 Fierravanti-Wells Indian Clinical Trials - Trending Costs (PDF 191KB) 04/04/2013
245 1 Di Natale Antimicrobial Resistance Committee (PDF 151KB) 14/05/2013
246 Whole of Portfolio Fierravanti-Wells OzHealth App for the AIHW's Australia's Health 2012 Report (PDF 246KB) 21/03/2013
247 4 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
248 4 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
249 Whole of Portfolio Fierravanti-Wells Overseas Delegations (PDF 693KB) 14/05/2013
250 3 Fierravanti-Wells MBS Items (PDF 109KB) 10/04/2013
251 8 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
252 5 Fierravanti-Wells Medicare Locals (PDF 141KB) 24/04/2013
253 11 Fierravanti-Wells Medicare Locals (PDF 179KB) 11/04/2013
254 1 Fierravanti-Wells PIP Implants (PDF 204KB) 14/05/2013
255 13 Fierravanti-Wells NPA on Improving Health Services in Tasmania (PDF 220KB) 14/05/2013
256 2 Di Natale PBAC Listing Times (PDF 302KB) 14/05/2013
257 8 Fierravanti-Wells * Transferred to cross portfolio Indigenous matters webpage    
258 8 Siewert * Transferred to cross portfolio Indigenous matters webpage    

 

Tabled Documents and additional information

Status of GP Super Clinics as at 7 February 2013 - additional information supplied to the committee by the Department of Health and Ageing on 7 February 2013 (PDF 85KB)
Estimated Expenses by Program - Outcome 4 - tabled on 13 February 2013 by Ms Rosemary Huxtable, Deputy Secretary, Department of Health and Ageing (PDF 158KB)
Australian Organ and Tissue Donation and Transplantation Authority Performance Report 2012 - tabled on 13 February 2013 by Ms Yael Cass, CEO, Australian Organ and Tissue Donation and Transplantation Authority (PDF 1689KB)
Post-PBAC listing times for high-cost medicines have Improved under the MOU - Pradaxa the exception - tabled on 13 February 2013 by Senator Di Natale (PDF 1081KB)
National Residential Medication Chart - tabled on 13 February 2013 by Professor Debora Picone, CEO, Australian Commission on Safety and Quality in Health Care (PDF 653KB)
Recommendations: Hear Us Inquiry into Hearing Health in Australia - additional information supplied to the committee by the Department of Health and Ageing on 15 February 2013 (PDF 406KB)
Letter of Clarification from Mr Steve McCutcheon, Chief Executive Officer, Food Standards Australia and New Zealand, regarding his appearance at the Senate additional estimates hearing on 13 February 2013 (PDF 205KB)
Letter of Clarification from Mr Ben Vincent, Assistant Secretary, Aged Care Programs Branch, regarding his appearance at the Senate additional estimates hearing on 13 February 2013 (PDF 164KB)
Letter of Clarification from Ms Louise Sylvan, Chief Executive Officer, Australian National Preventive Health Agency, relating to evidence provided by the ANPHA at additional estimates on 13 February 2013 (PDF 229KB)

For further information, contact:

Estimates Officer
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone: +61 2 6277 3517
Fax: +61 2 6277 5829
Email: community.affairs.sen@aph.gov.au